Who We Are
The Beer for Brains Foundation is a national, non-profit organization of craft-beer lovers, distributors and brewers, who are committed to:
- Raising public awareness about brain cancer
- Engendering compassion for its victims and
- Helping fund groundbreaking research leading to a cure.
- Based in Arizona we also are one of only a handful of beer industry-related charities currently operating in the United States.
What We Do
Each year, we stage unique, large-scale craft-beer appreciation/fundraising events across the country, working independently or in partnership with breweries and local organizations. Our events run the gamut from open parties featuring huge assortments of rare, craft beers and an equally diverse – and off-beat – assortment of foods and entertainers to local chef beer-wine food pairing competitions, special craft-beer educational dinners and much more. BFBF events are all about having fun while supporting a worthy cause.
The money we raise currently goes to support the development of cutting-edge brain cancer research and treatment options GBM Agile. The GBM AGILE Global Team is creating a knowledge-based adaptive standing clinical trial (learning system) – that can identify more effective therapies faster and more efficiently – for the benefit of GBM patients. GBM AGILE is being developed through the National Biomarker Development Alliance (NBDA), a non-profit organization created as part of the Research Collaboratory at Arizona State University (ASU). The NBDA’s mission is to collaboratively create standards-based, end-to-end systems solutions for biomarker discovery, development and delivery to advance precision medicine.
Learn more about upcoming BFBF events and updates to:
- Shop for head-turning BFBF t-shirts, hats and more
- Volunteer your time
- Sign-up to get news about important brain cancer treatment breakthroughs
- Follow up on social media and share your photos, thoughts and comments with us on:
Why We Do It
Brain cancer is the second leading type of cancer in children under age 5 and the third-most common type in young adults. This year, 22,070 new patients in the U.S. will be diagnosed with the disease, and nearly 13,000 people – or slightly more than one-in-ten of all U.S. brain cancer patients – will die from it.
For many adults, a brain cancer diagnosis remains a death sentence. The life expectancy of those suffering from gliomas, the most common and most aggressive form of brain tumor, has changed little in 40 years. On average, patients die within 9-12 months of receiving the diagnosis. Yet the cruelest aspect of this illness is the way it attacks individuals from within – steadily robbing them of their ability to perform basic tasks and making it increasingly difficult for them to interact with loved ones and the world around them. Brain cancer alters personalities. It impairs mental functions, disrupts speech, paralyzes limbs and, ultimately, leaves its victims with little freedom or dignity. It not only takes lives, it drastically reduces quality of life.